- Home
- LINC vs TERN Comparison
LINC vs TERN Comparison
Compare LINC & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LINC
- TERN
- Stock Information
- Founded
- LINC 1946
- TERN 2017
- Country
- LINC United States
- TERN United States
- Employees
- LINC N/A
- TERN N/A
- Industry
- LINC Other Consumer Services
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- LINC Real Estate
- TERN Health Care
- Exchange
- LINC Nasdaq
- TERN Nasdaq
- Market Cap
- LINC 732.0M
- TERN 710.6M
- IPO Year
- LINC 2005
- TERN 2021
- Fundamental
- Price
- LINC $17.74
- TERN $18.37
- Analyst Decision
- LINC Strong Buy
- TERN Buy
- Analyst Count
- LINC 4
- TERN 11
- Target Price
- LINC $24.50
- TERN $21.09
- AVG Volume (30 Days)
- LINC 266.5K
- TERN 4.2M
- Earning Date
- LINC 11-10-2025
- TERN 11-12-2025
- Dividend Yield
- LINC N/A
- TERN N/A
- EPS Growth
- LINC 79.82
- TERN N/A
- EPS
- LINC 0.46
- TERN N/A
- Revenue
- LINC $467,763,000.00
- TERN N/A
- Revenue This Year
- LINC $14.51
- TERN N/A
- Revenue Next Year
- LINC $8.40
- TERN N/A
- P/E Ratio
- LINC $39.08
- TERN N/A
- Revenue Growth
- LINC 14.53
- TERN N/A
- 52 Week Low
- LINC $14.10
- TERN $1.87
- 52 Week High
- LINC $25.76
- TERN $18.75
- Technical
- Relative Strength Index (RSI)
- LINC 25.01
- TERN 86.36
- Support Level
- LINC $17.29
- TERN $7.87
- Resistance Level
- LINC $18.88
- TERN $18.74
- Average True Range (ATR)
- LINC 0.91
- TERN 1.27
- MACD
- LINC -0.54
- TERN 1.13
- Stochastic Oscillator
- LINC 7.19
- TERN 93.96
About LINC Lincoln Educational Services Corporation
Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include; Campus Operations, and Transitional. The majority of the revenue is generated from the Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.